The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
Effects of hepatoprotectants in the treatment of nonalcoholic fatty liver disease
Author(s): 
Pages: 526-529,537
Year: Issue:  9
Journal: World Clinical Drugs

Abstract: 非酒精性脂肪性肝病(NAFLD)的早期干预已获得大多数学者认同.保肝抗炎药物包括多烯磷脂酰胆碱、维生素E、水飞蓟素、熊去氧胆酸、甘草酸制剂和己酮可可碱等,是NAFLD综合治疗的重要组成部分.本文重点综述保肝抗炎药物的适用人群及常用药物的选用.多项临床研究提示,保肝抗炎药物町改善NAFLD患者的临床症状和血清氨基转移酶水平,但大多数保肝抗炎药物对肝脏纤维化进程的改善依据尚不足.
Related Articles
No related articles found